New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Witowski, Janusz ^a,b   Kawka, Edyta ^a,b   Rudolf, Andras ^a   Jörres, Achim ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CALVASCULIN; CD34 ANTIGEN; CD40 LIGAND; COLLAGEN TYPE 1; CXCL1 CHEMOKINE; CYTOKERATIN; GLUCOSE DEGRADATION PRODUCT; HEME OXYGENASE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEAR FACTOR OF ACTIVATED T CELL 5; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; CYTOKINE; DIALYSIS FLUID;

CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CYTOLOGY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; FIBROSING ALVEOLITIS; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; LUNG FIBROBLAST; MESOTHELIUM CELL; MYOFIBROBLAST; NEUTROPHIL; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM CELL; PERITONITIS; PHENOTYPE; REVIEW; SPINDLE CELL; UPREGULATION; ADVERSE EFFECTS; DRUG EFFECTS; IMMUNOLOGY; PATHOLOGY; PERITONEUM;

CYTOKINES; DIALYSIS SOLUTIONS; FIBROBLASTS; HUMANS; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM;

EID: 84944187924     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/134708     Document Type: Review

References (67)

1. J. L. Rinn, C. Bondre, H. B. Gladstone, P. O. Brown, and H. Y. Chang, "Anatomic demarcation by positional variation in fibroblast gene expression programs," PLoS Genetics, vol. 2, no. 7, article e119, 2006.
2. R. R. Driskell and F. M. Watt, "Understanding fibroblast heterogeneity in the skin," Trends in Cell Biology, vol. 25, no. 2, pp. 92-99, 2015.
3. J. D. Williams, K. J. Craig, N. Topley et al. , "Morphologic changes in the peritoneal membrane of patients with renal disease," Journal of the American Society of Nephrology, vol. 13, no. 2, pp. 470-479, 2002.
4. J. D. Williams, K. J. Craig, C. VonRuhland,N. Topley, andG. T. Williams, "The natural course of peritoneal membrane biology during peritoneal dialysis," Kidney International, Supplement, vol. 64, no. 88, pp. S43-S49, 2003.
5. J. Witowski and A. Jörres, "Peritoneal cell culture: fibroblasts," Peritoneal Dialysis International, vol. 26, no. 3, pp. 292-299, 2006.
6. F. Strutz, H. Okada, C. W. Lo et al. , "Identification and characterization of a fibroblast marker: FSP1," Journal of Cell Biology, vol. 130, no. 2, pp. 393-405, 1995.
7. R. Kalluri and E. G. Neilson, "Epithelial-mesenchymal transition and its implications for fibrosis," The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1776-1784, 2003.
8. M. Le Hir, I. Hegyi, D. Cueni-Loffing, J. Loffing, and B. Kaissling, "Characterization of renal interstitial fibroblastspecific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys," Histochemistry and Cell Biology, vol. 123, no. 4-5, pp. 335-346, 2005.
9. J. Loureiro, A. Aguilera, R. Selgas et al. , "Blocking TGF-1 protects the peritoneal membrane from dialysate-induced damage," Journal of the American Society of Nephrology, vol. 22, no. 9, pp. 1682-1695, 2011.
10. J. Loureiro,M. Schilte, A. Aguilera et al. , "BMP-7 blocksmesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure," Nephrology Dialysis Transplantation, vol. 25, no. 4, pp. 1098-1108, 2010.
11. R. Catar, J. Witowski, P. Wagner et al. , "The proto-oncogene CFos transcriptionally regulates VEGF production during peritoneal inflammation," Kidney International, vol. 84, no. 6, pp. 1119-1128, 2013.
12. L. Koumas, T. J. Smith, S. Feldon,N. Blumberg, and R. P. Phipps, "Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes," American Journal of Pathology, vol. 163, no. 4, pp. 1291-1300, 2003.
13. L. Koumas and R. P. Phipps, "Differential COX localization and PG release in Thy-1+ and Thy-1? human female reproductive tract fibroblasts," The American Journal of Physiology: Cell Physiology, vol. 283, no. 2, pp. C599-C608, 2002.
14. T. J. Smith, L. Koumas, A. Gagnon et al. , "Orbital fibroblast heterogeneity may determine the clinical presentation of thyroidassociated ophthalmopathy," Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 1, pp. 385-392, 2002.
15. Y. Zhou, J. S. Hagood, and J. E. Murphy-Ullrich, "Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli," American Journal of Pathology, vol. 165, no. 2, pp. 659-669, 2004.
16. Y. Y. Sanders, P. Kumbla, and J. S. Hagood, "Enhanced myofibroblastic differentiation and survival in thy-1(?) lung fibroblasts," American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 2, pp. 226-235, 2007.
17. G. Ramrez, J. S. Hagood, Y. Sanders et al. , "Absence ofThy-1 results in TGF-induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts," Laboratory Investigation, vol. 91, no. 8, pp. 1206-1218, 2011.
18. J. S. Hagood, P. Prabhakaran, P. Kumbla et al. , "Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis," American Journal of Pathology, vol. 167, no. 2, pp. 365-379, 2005.
19. J. Kitayama, S. Emoto, H. Yamaguchi, H. Ishigami, and T. Watanabe, "CD90(+) mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment," PLoS ONE, vol. 9, no. 1, Article ID e86516, 2014.
20. N. Jovanovíc, S. Zuníc-Bozinovski, D. Trpinac et al. , "Ultrastructural changes of the peritoneum in a rabbit model of peritoneal dialysis," Vojnosanitetski Pregled, vol. 70, no. 11, pp. 1023-1028, 2013.
21. J. A. Jiménez-Heffernan, A. Aguilera, L. S. Aroeira et al. , "Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysisinduced fibrosis," Virchows Archiv, vol. 444, no. 3, pp. 247-256, 2004.
22. J. Loureiro, P. Sandoval, G. del Peso et al. , "Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis," PLoS ONE, vol. 8, no. 4, Article ID e61165, 2013.
23. H. Seeger, N. Braun, J. Latus et al. , "Platelet-derived growth factor receptor-beta expression in human peritoneum," Nephron Clinical Practice, vol. 128, no. 1-2, pp. 178-184, 2014.
24. M. Mack and M. Yanagita, "Origin of myofibroblasts and cellular events triggering fibrosis," Kidney International, vol. 87, pp. 297-307, 2015.
25. L. S. Aroeira, A. Aguilera, J. A. Sánchez-Tomero et al. , "Epithelial to mesenchymal transition and peritonealmembrane failure in peritoneal dialysis patients: Pathologic significance and potential therapeutic interventions," Journal of the American Society of Nephrology, vol. 18, no. 7, pp. 2004-2013, 2007.
26. K. Honda, C. Hamada, M. Nakayama et al. , "Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: A quantitative study of peritoneal membrane morphology," Clinical Journal of the American Society of Nephrology, vol. 3, no. 3, pp. 720-728, 2008.
27. K. Shioshita, M. Miyazaki, Y. Ozono et al. , "Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis," Kidney International, vol. 57, no. 2, pp. 619-631, 2000.
28. M. A. M. Mateijsen, A. C. van der Wal, P. M. E. M. Hendriks et al. , "Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis," Peritoneal Dialysis International, vol. 19, no. 6, pp. 517-525, 1999.
29. L. Daz-Flores, R. Gutiérrez, M. P. Garca et al. , "CD34+ stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells. Location, morphology, function and role in pathology," Histology and Histopathology, vol. 29, no. 7, pp. 831-870, 2014.
30. M. Yáñez-Mó, E. Lara-Pezzi, R. Selgas et al. , "Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells," The New England Journal of Medicine, vol. 348, no. 5, pp. 403-413, 2003.
31. O. Devuyst, P. J. Margetts, and N. Topley, "The pathophysiology of the peritoneal membrane," Journal of the American Society of Nephrology, vol. 21, no. 7, pp. 1077-1085, 2010.
32. Y. Liu, Z. Dong, H. Liu, J. Zhu, F. Liu, andG. Chen, "Transition ofmesothelial cell tofibroblast inperitonealdialysis: EMT, stem cell or bystander?" Peritoneal Dialysis International, vol. 35, no. 1, pp. 14-25, 2015.
33. S. E. Mutsaers, K. Birnie, S. Lansley, S. E. Herrick, C. Lim, and C. M. Prele, "Mesothelial cells in tissue repair and fibrosis," Frontiers in Pharmacology, vol. 6, article 113, 2015.
34. E. Sánchez-Tilló, Y. Liu, O. de Barrios et al. , "EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness," Cellular and Molecular Life Sciences, vol. 69, no. 20, pp. 3429-3456, 2012.
35. A. H. Yang, J. Y. Chen, and J. K. Lin, "Myofibroblastic conversion of mesothelial cells," Kidney International, vol. 63, no. 4, pp. 1530-1539, 2003.
36. P. J. Margetts, P. Bonniaud, L. Liu et al. , "Transient overexpression of TGF-beta1 induces epithelial mesenchymal transition in the rodent peritoneum," Journal of the American Society of Nephrology, vol. 16, no. 2, pp. 425-436, 2005.
37. R. Strippoli, I. Benedicto, M. L. P. Lozano et al. , "Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells," PLoS ONE, vol. 7, no. 2,Article ID e31492, 2012.
38. R. Strippoli, I. Benedicto, M. Foronda et al. , "p38 maintains E-cadherin expression by modulating TAK1-NF-B during epithelial-to-mesenchymal transition," Journal of Cell Science, vol. 123, no. 24, pp. 4321-4331, 2010.
39. Q. Liu, Y. Zhang, H. Mao et al. , "A crosstalk between the Smad and JNK signaling in the TGF-induced epithelialmesenchymal transition in rat peritoneal mesothelial cells," PLoS ONE, vol. 7, no. 2,Article ID e32009, 2012.
40. Y.-H. Jang, H.-S. Shin, H. Sun Choi et al. , "Effects of dexamethasone on the TGF-beta1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells," Laboratory Investigation, vol. 93, no. 2, pp. 194-206, 2013.
41. R. Strippoli, I. Benedicto,M. L. P. Lozano, A. Cerezo,M. López-Cabrera, and M. A. Del Pozo, "Epithelial-to-mesenchymal transition of peritonealmesothelial cells is regulated by an ERK/NFkappaB/ Snail1 pathway," DiseaseModels andMechanisms, vol. 1, no. 4-5, pp. 264-274, 2008.
42. P. Patel, Y. Sekiguchi, K.-H. Oh, S. E. Patterson, M. R. J. Kolb, and P. J. Margetts, "Smad3-dependent and-independent pathways are involved in peritoneal membrane injury," Kidney International, vol. 77, no. 4, pp. 319-328, 2010.
43. R. Vargha, M. Endemann, K. Kratochwill et al. , "Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents," Nephrology Dialysis Transplantation, vol. 21, no. 10, pp. 2943-2947, 2006.
44. C. Li, Y. Ren, X. Jia et al. , "Twist overexpression promoted epithelial-to-mesenchymal transition of human peritoneal mesothelial cells under high glucose," Nephrology Dialysis Transplantation, vol. 27, no. 11, pp. 4119-4124, 2012.
45. M.-A. Yu, K.-S. Shin, J. H. Kim et al. , "HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium," Journal of the American Society of Nephrology, vol. 20, no. 3, pp. 567-581, 2009.
46. T. Y. H. Wong, A. O. Phillips, J. Witowski, and N. Topley, "Glucose-mediated induction of TGF-beta1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent," Kidney International, vol. 63, no. 4, pp. 1404-1416, 2003.
47. K. Bang, J. Jeong, J. H. Shin et al. , "Heme oxygenase-1 attenuates epithelial-to-mesenchymal transition of human peritoneal mesothelial cells," Clinical and Experimental Nephrology, vol. 17, no. 2, pp. 284-293, 2013.
48. D. J. Abraham, B. Eckes, V. Rajkumar, and T. Krieg, "New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma," Current Rheumatology Reports, vol. 9, no. 2, pp. 136-143, 2007.
49. G. del Peso, J. A. Jimenez-Heffernan, M. A. Bajo et al. , "Epithelial-to-mesenchymal transition ofmesothelial cells is an early event during peritoneal dialysis and is associatedwith high peritoneal transport," Kidney International Supplements, vol. 73, no. 108, pp. S26-S33, 2008.
50. P. J. Margetts, M. Kolb, L. Yu et al. , "Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum," The American Journal of Pathology, vol. 160, no. 6, pp. 2285-2294, 2002.
51. M. A. Bajo, M. L. Prez-Lozano, P. Albar-Vizcaino et al. , "Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid," Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 282-291, 2011.
52. A. Fernández-Perpén, M. L. Pérez-Lozano, M.-A. Bajo et al. , "Influence of bicarbonate/low-GDP peritoneal dialysis fluid (Bicavera) on in vitro and ex vivo epithelial-to-mesenchymal transition ofmesothelial cells," Peritoneal Dialysis International, vol. 32, no. 3, pp. 292-304, 2012.
53. I. Hirahara, Y. Ishibashi, S. Kaname, E. Kusano, and T. Fujita, "Methylglyoxal induces peritoneal thickening bymesenchymallike mesothelial cells in rats," Nephrology Dialysis Transplantation, vol. 24, no. 2, pp. 437-447, 2009.
54. O. Busnadiego, J. Loureiro-Alvarez, P. Sandoval et al. , "A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis," Journal of the American Society of Nephrology, vol. 26, no. 1, pp. 173-182, 2015.
55. R. Dixit, X. Ai, and A. Fine, "Derivation of lung mesenchymal lineages from the fetal mesothelium requires hedgehog signaling for mesothelial cell entry," Development, vol. 140, no. 21, pp. 4398-4406, 2013.
56. Y. Li, J. Wang, and K. Asahina, "Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelialmesenchymal transition in liver injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 6, pp. 2324-2329, 2013.
57. S. Karki, R. Surolia, T. D. Hock et al. , "Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis," The FASEB Journal, vol. 28, no. 3, pp. 1122-1131, 2014.
58. Y.-T. Chen, Y.-T. Chang, S.-Y. Pan et al. , "Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury," Journal of the American Society of Nephrology, vol. 25, no. 12, pp. 2847-2858, 2014.
59. N. Sakai, J. Chun, J. S. Duffield, T. Wada, A. D. Luster, and A. M. Tager, "LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation," The FASEB Journal, vol. 27, no. 5, pp. 1830-1846, 2013.
60. T. A. Wynn and T. R. Ramalingam, "Mechanisms of fibrosis: Therapeutic translation for fibrotic disease," Nature Medicine, vol. 18, no. 7, pp. 1028-1040, 2012.
61. J. Witowski,A. Thiel, R. Dechend et al. , "Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts: induction by macrophage-derived cytokines,"American Journal of Pathology, vol. 158, no. 4, pp. 1441-1450, 2001.
62. J. Witowski, H. Tayama, K. Ksiek, M. Wanic-Kossowska, T. O. Bender, and A. Jörres, "Human peritoneal fibroblasts are a potent source of neutrophil-targeting cytokines: A key role of IL-1stimulation," Laboratory Investigation, vol. 89, no. 4, pp. 414-424, 2009.
63. E. Kawka, J. Witowski, N. Fouqet et al. , "Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: A key role of IFN-,"Mediators of Inflammation, vol. 2014,Article ID 590654, 9 pages, 2014.
64. C. Verger, A. Luger, H. L. Moore, and K. D. Nolph, "Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury," Kidney International, vol. 23, no. 6, pp. 823-831, 1983.
65. B. Haslinger-Löffler, B. Wagner,M. Brück et al. , "Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells," Kidney International, vol. 70, no. 6, pp. 1089-1098, 2006.
66. D. Kitterer, J. Latus, C. Ulmer et al. , "Activation of nuclear factor of activated T cells 5 in the peritoneal membrane of uremic patients," The American Journal of Physiology-Renal Physiology, vol. 308, no. 11, pp. F1247-F1258, 2015.
67. R. S. Smith, T. J. Smith, T. M. Blieden, and R. P. Phipps, "Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation,"TheAmericanJournal of Pathology, vol. 151, no. 2, pp. 317-322, 1997.